ADVANCED PREDICTIVE MODELING FOR THE BIOFIRE FILMARRAY SYSTEM IN INFECTIOUS DISEASE DIAGNOSTICS

B ADEEL; Q NAZIR; U NAVEED; A NAZ; Z ABRAR

doi:10.54112/bcsrj.v2024i1.1237

Authors

B ADEEL Department of Microbiology, Rashid Latif Medical College Lahore, Pakistan
Q NAZIR Institute of Biochemistry & Biotechnology, University of Veterinary and Animal Sciences Lahore, Pakistan
U NAVEED Department of Biological Sciences, The Superior University, Lahore, Pakistan
A NAZ Department of Biological Sciences, The Superior University, Lahore, Pakistan
Z ABRAR Institute of Public Health, University of Lahore, Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1237

Keywords:

BioFire FilmArray System, Mathematical model, Diagnostic accuracy, Sensitivity prediction, Sample type, Pathogen load

Abstract

The Bio Fire Film Array System has emerged as a powerful tool in clinical diagnostics, offering rapid and multiplexed detection of infectious pathogens. This study presents the development of a comprehensive mathematical model aimed at predicting the accuracy and sensitivity of the BioFire FilmArray System under diverse conditions. Key factors such as sample type, pathogen load, specimen characteristics, and environmental variables were systematically analyzed to elucidate their impact on the system's performance. The model incorporates a range of parameters including sample volume, specimen complexity, microbial diversity, and system-specific variables to generate probabilistic estimates of diagnostic outcomes. By leveraging large datasets encompassing diverse clinical scenarios and pathogen profiles, the model achieves robustness and generalizability, thereby facilitating its applicability across different healthcare settings and populations. Validation of the model against independent datasets demonstrates its efficacy in accurately predicting the performance of the BioFire FilmArray System across a spectrum of conditions. Overall, this mathematical model represents a significant advancement in optimizing the utility of the BioFire FilmArray System for infectious disease diagnosis. Its integration into clinical practice holds promise for improving patient care, guiding sample processing protocols, and informing decision-making processes in infectious disease management.

Downloads

Download data is not yet available.

References

Trujillo-Gomez J, Tsokani S, Arango-Ferreira C, Atehortua-Munoz S, Jimenez-Villegas MJ, Serrano-Tabares C, et al. Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: a systematic review and diagnostic test accuracy meta-analysis. EClinicalMedicine. 2022;44.

Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis. Clinical Microbiology and Infection. 2020;26(3):281-90.

Sze DT, Lau CC, Chan T-M, Ma ES, Tang BS. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels. BMC microbiology. 2021;21:1-15.

Leber AL, Everhart K, Daly JA, Hopper A, Harrington A, Schreckenberger P, et al. Multicenter evaluation of BioFire FilmArray respiratory panel 2 for detection of viruses and bacteria in nasopharyngeal swab samples. Journal of Clinical Microbiology. 2018;56(6):10.1128/jcm. 01945-17.

Fhooblall M, Nkwanyana F, Mlisana KP. Evaluation of the BioFire® FilmArray® Blood Culture Identification Panel on positive blood cultures in a regional hospital laboratory in KwaZulu-Natal. African Journal of Laboratory Medicine. 2016;5(1):1-8.

Jones S, Janto C, Balgahom R, Samarasekara H, Branley J. Evaluation of the biofire filmarray blood culture identification panel on positive blood cultures in a regional hospital laboratory. Pathology. 2018;50:S114-S5.

Cortazzo V, D’Inzeo T, Giordano L, Menchinelli G, Liotti FM, Fiori B, et al. Comparing BioFire FilmArray BCID2 and BCID panels for direct detection of bacterial pathogens and antimicrobial resistance genes from positive blood cultures. Journal of Clinical Microbiology. 2021;59(4):10.1128/jcm. 03163-20.

Ward C, Stocker K, Begum J, Wade P, Ebrahimsa U, Goldenberg S. Performance evaluation of the Verigene®(Nanosphere) and FilmArray®(BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases. 2015;34:487-96.

Machiels JD, Cremers AJ, van Bergen-Verkuyten MC, Paardekoper-Strijbosch SJ, Frijns KC, Wertheim HF, et al. Impact of the BioFire FilmArray gastrointestinal panel on patient care and infection control. PLoS One. 2020;15(2):e0228596.

Edin A, Eilers H, Allard A. Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections. Infectious Diseases. 2020;52(7):479-88.

Southern TR, VanSchooneveld TC, Bannister DL, Brown TL, Crismon AS, Buss SN, et al. Implementation and performance of the BioFire FilmArray® Blood Culture Identification panel with antimicrobial treatment recommendations for bloodstream infections at a midwestern academic tertiary hospital. Diagnostic Microbiology and Infectious Disease. 2015;81(2):96-101.

Kyriazopoulou E, Karageorgos A, Liaskou-Antoniou L, Koufargyris P, Safarika A, Damoraki G, et al. BioFire® FilmArray® Pneumonia Panel for severe lower respiratory tract infections: subgroup analysis of a randomized clinical trial. Infectious Diseases and Therapy. 2021;10:1437-49.

Murphy CN, Fowler R, Balada-Llasat JM, Carroll A, Stone H, Akerele O, et al. Multicenter evaluation of the BioFire FilmArray pneumonia/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. Journal of Clinical Microbiology. 2020;58(7):10.1128/jcm. 00128-20.

Obaro S, Hassan-Hanga F, Medugu N, Olaosebikan R, Olanipekun G, Jibir B, et al. Comparison of bacterial culture with BioFire® FilmArray® multiplex PCR screening of archived cerebrospinal fluid specimens from children with suspected bacterial meningitis in Nigeria. BMC Infectious Diseases. 2023;23(1):641.

Gastli N, Loubinoux J, Daragon M, Lavigne J-P, Saint-Sardos P, Pailhoriès H, et al. Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia. Clinical Microbiology and Infection. 2021;27(9):1308-14.

Kosai K, Akamatsu N, Ota K, Mitsumoto-Kaseida F, Sakamoto K, Hasegawa H, et al. BioFire FilmArray Pneumonia Panel enhances detection of pathogens and antimicrobial resistance in lower respiratory tract specimens. Annals of Clinical Microbiology and Antimicrobials. 2022;21(1):24.

Mponponsuo K, Leal J, Spackman E, Somayaji R, Gregson D, Rennert-May E. Mathematical model of the cost-effectiveness of the BioFire FilmArray Blood Culture Identification (BCID) Panel molecular rapid diagnostic test compared with conventional methods for identification of Escherichia coli bloodstream infections. Journal of Antimicrobial Chemotherapy. 2022;77(2):507-16.

Acuña M, Benadof D, Yohannessen K, Leiva Y, Clement P. FilmArray® Meningoencephalitis panel in the diagnosis of central nervous system infections: stewardship and cost analysis in a paediatric hospital in Chile. BMC pediatrics. 2022;22(1):1-11.

Mponponsuo K. BioFire FilmArray Blood Culture system cost saving for identifying E. coli bloodstream infections. PharmacoEconomics & Outcomes News. 2021;892:4-27.

Ng AH, Hu H, Wang K, Scherler K, Warren SE, Zollinger DR, et al. Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2. Cell Reports. 2023;42(10).

Doyle B, Rihal CS, O’Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. 2007;116(21):2391-8.

Murphy C, Fowler R, Iwen PC, Fey PD. Evaluation of the BioFire FilmArray® GastrointestinalPanel in a Midwestern academic hospital. European Journal of Clinical Microbiology & Infectious Diseases. 2017;36:747-54.

Berinson B, Both A, Berneking L, Christner M, Lütgehetmann M, Aepfelbacher M, et al. Usefulness of BioFire FilmArray BCID2 for blood culture processing in clinical practice. Journal of Clinical Microbiology. 2021;59(8):10.1128/jcm. 00543-21.

Buchan BW, Windham S, Balada-Llasat J-M, Leber A, Harrington A, Relich R, et al. Practical comparison of the BioFire FilmArray pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. Journal of Clinical Microbiology. 2020;58(7):10.1128/jcm. 00135-20.

Markovich K, Wingler MJB, Stover KR, Barber KE, Wagner JL, Cretella DA. Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center. Diseases. 2022;10(4):110.

Carmon D, Rohana H, Azrad M, Peretz A. The Impact of a Positive Biofire® FilmArray® Gastrointestinal Panel Result on Clinical Management and Outcomes. Diagnostics. 2023;13(6):1094.

Alashkar G, Parslow G. Evaluation of the BioFire Filmarray-2.0 Meningitis/Encephalitis and blood culture identification panels. New Zealand Journal of Medical Laboratory Science. 2020;74(3):228-9.

Rule R, Paruk F, Becker P, Neuhoff M, Chausse J, Said M. Clinical utility of the BioFire FilmArray Blood Culture Identification panel in the adjustment of empiric antimicrobial therapy in the critically ill septic patient. PLoS One. 2021;16(7):e0254389.